Objective To present a summary of the 2020 version of the European Association of Urology
(EAU)-European Association of Nuclear Medicine (EANM)-European Society for …

Context The coronavirus disease 2019 (COVID-19) pandemic is leading to delays in the
treatment of many urologic cancers. Objective To provide a contemporary picture of the risks …

Purpose: The summary presented herein represents Part I of the three-part series dedicated
to Clinically Localized Prostate Cancer: AUA/ASTRO Guideline, discussing risk assessment …

Focused ultrasound can deliver energy safely and non-invasively into tissues at depths of
centimetres. Here we show that the genetics and cellular functions of chimeric antigen …

Background Active surveillance (AS) is the preferred management option for most men with
grade group (GG) 1 prostate cancer (PCa). Questions persist regarding long-term outcomes …

The definition of clinically significant prostate cancer is a dynamic process that was initiated
many decades ago, when there was already evidence that a great proportion of patients with …

Active surveillance (AS) represents a well-recognized management option for many patients
with low-and very low-risk prostate cancer (PCa). AS aims to reduce overtreatment whilst …

Context Active surveillance (AS) is increasingly selected among patients with localized,
intermediate-risk (IR) prostate cancer (PCa). However, the safety and optimal candidate …

Objectives Active surveillance (AS), now the standard of care for most men with favourable‐
risk prostate cancer, is appealing for selected men with 'favourable'intermediate‐risk …

Prostate cancer is the second most frequently diagnosed non-skin cancer in men worldwide.
Patient outcomes are remarkably heterogeneous and the best existing clinical prognostic …